ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 075,68
0,99%
Dow Jones
38 884,26
0,08%
DAX
18 430,05
1,42%
Brent Oil
82,685
-0,22%
Bitcoin
62 777,41
0,71%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Nighthawk Biosciences Inc (NHWK)

  7. Nighthawk Biosciences Inc (NHWK) Actualités

NHWK

Nighthawk Biosciences (NHWK)

Nighthawk Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:NHWK
DateHeureSourceTitreSymboleSociété
03/05/202422h00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
03/05/202413h18Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
02/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/04/202422h52Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NHWKNighthawk Biosciences Inc
19/03/202413h30GlobeNewswire Inc.Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityAMEX:NHWKNighthawk Biosciences Inc
14/03/202413h30GlobeNewswire Inc.Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-ConsortiumAMEX:NHWKNighthawk Biosciences Inc
13/03/202411h17Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]AMEX:NHWKNighthawk Biosciences Inc
12/03/202422h00GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
08/03/202406h20GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
07/03/202422h18GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Proposed Public Offering of Common StockAMEX:NHWKNighthawk Biosciences Inc
07/03/202414h30GlobeNewswire Inc.Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023AMEX:NHWKNighthawk Biosciences Inc
06/02/202414h00GlobeNewswire Inc.NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayAMEX:NHWKNighthawk Biosciences Inc
01/02/202414h00GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerAMEX:NHWKNighthawk Biosciences Inc
30/01/202414h00GlobeNewswire Inc.NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteAMEX:NHWKNighthawk Biosciences Inc
25/01/202414h30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramAMEX:NHWKNighthawk Biosciences Inc
16/01/202414h30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientAMEX:NHWKNighthawk Biosciences Inc
08/01/202414h30GlobeNewswire Inc.NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOAMEX:NHWKNighthawk Biosciences Inc
03/01/202414h30GlobeNewswire Inc.NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityAMEX:NHWKNighthawk Biosciences Inc
21/12/202314h30GlobeNewswire Inc.NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research UniversityAMEX:NHWKNighthawk Biosciences Inc
19/12/202322h47Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
19/12/202322h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:NHWKNighthawk Biosciences Inc
18/12/202314h30GlobeNewswire Inc.NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical CompanyAMEX:NHWKNighthawk Biosciences Inc
12/12/202314h30GlobeNewswire Inc.NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core AssetsAMEX:NHWKNighthawk Biosciences Inc
20/11/202322h05GlobeNewswire Inc.NightHawk Biosciences Provides Q3 2023 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
14/08/202322h05GlobeNewswire Inc.NightHawk Biosciences Provides Q2 2023 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
15/05/202322h05GlobeNewswire Inc.NightHawk Biosciences Provides Q1 2023 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
31/03/202322h05GlobeNewswire Inc.NightHawk Biosciences Provides 2022 Year End Business UpdateAMEX:NHWKNighthawk Biosciences Inc
14/11/202222h01GlobeNewswire Inc.NightHawk Biosciences Provides Third Quarter 2022 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
21/10/202214h00GlobeNewswire Inc.Nighthawk Biosciences’ Scorpion Subsidiary Announces Grand Opening of its San Antonio FacilityAMEX:NHWKNighthawk Biosciences Inc
23/08/202213h30GlobeNewswire Inc.NightHawk Biosciences Announces Buildout of Advanced Biosafety Level 2 (BSL-2) LaboratoryAMEX:NHWKNighthawk Biosciences Inc
 Showing the most relevant articles for your search:AMEX:NHWK

Dernières Valeurs Consultées

NASDAQ
MSFT
Microsoft
EU
PX1
CAC 40
NYSE
MRK
Merck
USI
USTECH100
US Tech 100
EU
BNP
BNP Paribas
COIN
BTCUSD
Bitcoin
EU
ORA
Orange
EU
BEL20
Bel 20
EU
ML
Michelin
EU
SGO
Cie de SaintGobain
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
EU
GLE
Societe Generale
EU
ACA
Credit Agricole
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés